HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Murat Mert Atmaca Selected Research

Murat Mert Atmaca Research Topics

Disease

3Ischemic Stroke
11/2023 - 01/2020
3Epilepsia Partialis Continua
01/2018 - 08/2015
3Status Epilepticus (Complex Partial Status Epilepticus)
12/2017 - 08/2015
2Epilepsy (Aura)
01/2018 - 12/2017
1Stroke (Strokes)
11/2023
1Infections
11/2022
1COVID-19
11/2022
1Transthyretin-Related Hereditary Amyloidosis
01/2022
1Multiple Sclerosis
03/2021
1Hemorrhage
01/2020
1Seizures (Absence Seizure)
09/2018
1Double cortex
12/2017
1Neoplasms (Cancer)
12/2017
1Autoimmune Diseases of the Nervous System
12/2017

Drug/Important Bio-Agent (IBA)

3erucylphosphocholineIBA
01/2018 - 08/2015
2AntibodiesIBA
11/2023 - 12/2017
2ocrelizumabIBA
11/2022 - 03/2021
2Levetiracetam (Keppra)FDA LinkGeneric
10/2017 - 08/2015
1Prealbumin (Transthyretin)IBA
01/2022
1Anticonvulsants (Antiepileptic Drugs)IBA
09/2018
1Natalizumab (Tysabri)FDA Link
09/2018
1N-Methylaspartate (NMDA)IBA
12/2017
1gamma-Aminobutyric Acid (GABA)IBA
12/2017
1AutoantibodiesIBA
12/2017
1Phenytoin (Dilantin)FDA LinkGeneric
10/2017

Therapy/Procedure

2Therapeutics
11/2022 - 11/2021
1Duration of Therapy
11/2022
1Thrombolytic Therapy
01/2020